Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized, Subject And Investigator Blinded, Sponsor Open Placebo Controlled, 2 Way, Crossover Phase 1b Study To Examine The Effects Of PF-04958242 On Ketamine Induced Cognitive Impairment In Healthy Male Volunteers


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01749098

Organisation Name: Biogen

Overal Status: Completed

Start Date: December 2012

Last Update: November 21, 2019

Lead Sponsor: Biogen

Brief Summary: To assess if PF-04958242 can attenuate the ketamine-induced cognitive impairment in verbal learning and memory, episodic memory and spatial working memory in healthy volunteers.

Conditions:
  • Schizophrenia


Total execution time in seconds: 0.14978909492493